Skip to main content
. 2019 Apr 5;74(Suppl 3):iii11–iii18. doi: 10.1093/jac/dkz086

Table 4.

Plasma and ELF exposure measures following a single subcutaneous lefamulin dosea

Dose (mg/kg) Matrix Cmax (mg/L) AUC0–24 (mg·h/L) AUC0–24 (mg·h/L)/dose (mg/kg)
35 plasma 1.74 5.13 0.147
ELF 2.47 10.7 0.305
70 plasma 2.46 8.66 0.124
ELF 2.96 17.6 0.251
a

Mean values of the dose-normalized AUC0–24 for plasma (0.136 mg·h/L per mg/kg) and ELF (0.278 mg·h/L per mg/kg) were used for the translation of dose to exposure.